These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9872991

  • 1. Domain-specific interactions between the p185(neu) and epidermal growth factor receptor kinases determine differential signaling outcomes.
    Qian X, O'Rourke DM, Fei Z, Zhang HT, Kao CC, Greene MI.
    J Biol Chem; 1999 Jan 08; 274(2):574-83. PubMed ID: 9872991
    [Abstract] [Full Text] [Related]

  • 2. The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling.
    Kumagai T, Davis JG, Horie T, O'Rourke DM, Greene MI.
    Proc Natl Acad Sci U S A; 2001 May 08; 98(10):5526-31. PubMed ID: 11320205
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Greene MI.
    Proc Natl Acad Sci U S A; 1988 Aug 08; 85(15):5389-93. PubMed ID: 2899889
    [Abstract] [Full Text] [Related]

  • 4. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu.
    Sottocornola E, Berra B, Colombo I.
    Biochim Biophys Acta; 2003 Dec 30; 1635(2-3):55-66. PubMed ID: 14729068
    [Abstract] [Full Text] [Related]

  • 5. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
    Wu CJ, Qian X, O'Rourke DM.
    DNA Cell Biol; 1999 Oct 30; 18(10):731-41. PubMed ID: 10541432
    [Abstract] [Full Text] [Related]

  • 6. Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation.
    Qian X, Dougall WC, Fei Z, Greene MI.
    Oncogene; 1995 Jan 05; 10(1):211-9. PubMed ID: 7824275
    [Abstract] [Full Text] [Related]

  • 7. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.
    Qian X, LeVea CM, Freeman JK, Dougall WC, Greene MI.
    Proc Natl Acad Sci U S A; 1994 Feb 15; 91(4):1500-4. PubMed ID: 7509075
    [Abstract] [Full Text] [Related]

  • 8. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF, Heffernan PA, Weinberg RA.
    Mol Cell Biol; 1986 May 15; 6(5):1729-40. PubMed ID: 2878363
    [Abstract] [Full Text] [Related]

  • 9. The extracellular domain of p185(c-neu) induces density-dependent inhibition of cell growth in malignant mesothelioma cells and reduces growth of mesothelioma in vivo.
    Yoneda T, Kumagai T, Nagatomo I, Furukawa M, Yamane H, Hoshino S, Mori M, Takeda Y, Horai T, Nishida S, Watanabe D, Kijima T, Yoshida M, Osaki T, Tachibana I, Greene MI, Kawase I.
    DNA Cell Biol; 2006 Sep 15; 25(9):530-40. PubMed ID: 16989576
    [Abstract] [Full Text] [Related]

  • 10. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation.
    Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ.
    J Biol Chem; 1997 Feb 14; 272(7):4637-44. PubMed ID: 9020193
    [Abstract] [Full Text] [Related]

  • 11. ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.
    Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE.
    Mol Cell Biol; 1998 Sep 14; 18(9):5042-51. PubMed ID: 9710588
    [Abstract] [Full Text] [Related]

  • 12. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG, Hosick HL, Ethier SP.
    J Cell Physiol; 2000 Jun 14; 183(3):301-13. PubMed ID: 10797304
    [Abstract] [Full Text] [Related]

  • 13. p66Shc isoform down-regulated and not required for HER-2/neu signaling pathway in human breast cancer cell lines with HER-2/neu overexpression.
    Xie Y, Hung MC.
    Biochem Biophys Res Commun; 1996 Apr 05; 221(1):140-5. PubMed ID: 8660324
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
    O'Rourke DM, Nute EJ, Davis JG, Wu C, Lee A, Murali R, Zhang HT, Qian X, Kao CC, Greene MI.
    Oncogene; 1998 Mar 05; 16(9):1197-207. PubMed ID: 9528862
    [Abstract] [Full Text] [Related]

  • 15. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation.
    Burke CL, Lemmon MA, Coren BA, Engelman DM, Stern DF.
    Oncogene; 1997 Feb 13; 14(6):687-96. PubMed ID: 9038376
    [Abstract] [Full Text] [Related]

  • 16. Association of signaling proteins with a nonmitogenic heterodimeric complex composed of epidermal growth factor receptor and kinase-inactive p185c-neu.
    Dougall WC, Qian X, Miller MJ, Greene MI.
    DNA Cell Biol; 1996 Jan 13; 15(1):31-40. PubMed ID: 8561895
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y, Kim SO, Jiang J, Frank SJ.
    J Biol Chem; 2003 May 23; 278(21):18902-13. PubMed ID: 12642595
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.
    Qian X, O'Rourke DM, Zhao H, Greene MI.
    Oncogene; 1996 Nov 21; 13(10):2149-57. PubMed ID: 8950982
    [Abstract] [Full Text] [Related]

  • 19. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
    Zhang HT, O'Rourke DM, Zhao H, Murali R, Mikami Y, Davis JG, Greene MI, Qian X.
    Oncogene; 1998 Jun 04; 16(22):2835-42. PubMed ID: 9671404
    [Abstract] [Full Text] [Related]

  • 20. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
    Justman QA, Clinton GM.
    J Biol Chem; 2002 Jun 07; 277(23):20618-24. PubMed ID: 11934884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.